Evidence map›Paper›PMID 35859215›Full record

ArticleArchives of microbiology2022

Cationic polymer contributes to broaden the spectrum of vancomycin activity achieving eradication of Pseudomonas aeruginosa.

Melisa B Corti, Luciana P Campagno, Verónica L Romero, Silvina Gutierrez, Fabiana L Alovero

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Melisa B CortiDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba and Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET, Medina Allende y Haya de la Torre, Edificio Ciencias II, X5000HUA, Ciudad Universitaria, Córdoba, Argentina.
Luciana P CampagnoDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba and Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET, Medina Allende y Haya de la Torre, Edificio Ciencias II, X5000HUA, Ciudad Universitaria, Córdoba, Argentina.
Verónica L RomeroDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba and Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET, Medina Allende y Haya de la Torre, Edificio Ciencias II, X5000HUA, Ciudad Universitaria, Córdoba, Argentina.
Silvina GutierrezCentro de Microscopia Electrónica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
Fabiana L AloveroDepartamento de Ciencias Farmacéuticas, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba and Unidad de Investigación y Desarrollo en Tecnología Farmacéutica (UNITEFA), CONICET, Medina Allende y Haya de la Torre, Edificio Ciencias II, X5000HUA, Ciudad Universitaria, Córdoba, Argentina. fabiana.alovero@unc.edu.ar.ORCID http://orcid.org/0000-0003-4210-5516
Consejo Nacional de Investigaciones Científicas y Técnicas · ARUniversidad Nacional de Córdoba · AR

Funding

Fondo para la Investigación Científica y Tecnológica PICT2012-0173Secretaria de Ciencia y Tecnología - Universidad Nacional de Córdoba Res N° 411/18
6 · The paper itself

Abstract

Vancomycin (VAN) is unable to penetrate the outer membrane of Gram-negative bacteria and reach the target site. One approach to overcome this limitation is to associate it with compounds with permeabilizing or antimicrobial properties. Eudragit E100

Indexed as

Pseudomonas aeruginosaVancomycinAnti-Bacterial AgentsMicrobial Sensitivity TestsPolymersAnti-Bacterial AgentsPolymersVancomycinCationic polymerGlycopeptidesOuter membranePseudomonas aeruginosaTEMZeta potential

Identifiers

PMID35859215
OpenAlexW4286007920

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.